Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.
BMRN
BIOMARIN PHARMACEUTICAL INCData as of 2026 Q1 (03-31) · 13F snapshot
Summary
BIOMARIN PHARMACEUTICAL INC (BMRN) is held by 13 tracked hedge-fund managers, a combined reported value of ~$1.30B; the largest are Andreas Halvorsen, Ken Griffin, Paul Singer. This quarter: 3 added, 4 trimmed. 15 members of Congress have disclosed STOCK Act trades. Data as of 2026 Q1, from public SEC 13F filings, delayed up to ~45 days.
Attention · HighThis quarter · Mixed
Gurus holding13
Congress trades15
Price$55.95vs quarter-end-0.96%
Sectors0
This quarter's moves
Top holderAndreas HalvorsenNew0
Added3
Trimmed / sold4
Value $398.94M1.1% of portfolio7,062,0772026 Q1
Paul SingerHold
Value $247.44M2.3% of portfolio3,500,3382025 Q1
Dan LoebNew
Value $37.12M0.6% of portfolio385,0002023 Q4
George SorosHold
Value $12.85M0.4% of portfolio156,0532024 Q2
Value $7.28M— of portfolio128,8002026 Q1
Value $5.65M— of portfolio100,0002026 Q1
Value $3.28M— of portfolio58,0002026 Q1
Value $3.19M— of portfolio56,4002026 Q1
Value $1.19M— of portfolio20,0002025 Q4
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Andreas Halvorsen | $398.94M | 1.1% | Add |
| Paul Singer | $247.44M | 2.3% | Hold |
| Dan Loeb | $37.12M | 0.6% | New |
| George Soros | $12.85M | 0.4% | Hold |
| Ken GriffinCALL | $7.28M | — | — |
| Steven CohenCALL | $5.65M | — | — |
| Izzy EnglanderCALL | $3.28M | — | — |
| Ken GriffinPUT | $3.19M | — | — |
| Izzy EnglanderPUT | $1.19M | — | — |